Table 4.
Cox regression of protein expression in metastasis of breast cancer.
| Variable | B | SE | Wald | P-value | OR | OR 95% CI | |
|---|---|---|---|---|---|---|---|
| ER | − 0.551 | 0.544 | 1.026 | 0.311 | 0.576 | 0.198 | 1.674 |
| HER2 | − 0.615 | 0.727 | 0.714 | 0.398 | 0.541 | 0.130 | 2.250 |
| E-Cad | 0.158 | 0.384 | 0.170 | 0.680 | 1.171 | 0.552 | 2.487 |
| Ki67 | 0.357 | 0.466 | 0.585 | 0.445 | 1.428 | 0.573 | 3.563 |
| Molecular subtypes | |||||||
| Luminal A | – | – | – | – | Reference | Reference | Reference |
| Luminal B | − 0.332 | 0.602 | 0.305 | 0.581 | 0.717 | 0.220 | 2.334 |
| Luminal HER2 | − 0.194 | 0.631 | 0.094 | 0.759 | 0.824 | 0.239 | 2.839 |
| HER2-enriched | − 0.232 | 0.694 | 0.112 | 0.738 | 0.793 | 0.204 | 3.088 |
| Basal-like | − 0.615 | 0.727 | 0.714 | 0.398 | 0.541 | 0.130 | 2.250 |
| Lymph node metastasis | |||||||
| 0 | – | – | – | – | Reference | Reference | Reference |
| 1 ~ 3 | − 0.066 | 0.344 | 0.037 | 0.847 | 0.936 | 0.477 | 1.836 |
| 4 ~ 9 | 0.419 | 0.315 | 1.765 | 0.184 | 1.521 | 0.819 | 2.822 |
| ≥ 10 | 0.786 | 0.332 | 5.599 | 0.018 | 2.195 | 1.144 | 4.208 |
| MSH2 | − 0.064 | 0.041 | 2.453 | 0.117 | 0.938 | 0.865 | 1.016 |
| MLH1 | − 0.069 | 0.045 | 2.341 | 0.126 | 0.934 | 0.855 | 1.020 |
| PARP1 | 0.137 | 0.037 | 13.868 | < 0.001 | 1.147 | 1.067 | 1.233 |
| XRCC1 | 0.108 | 0.044 | 5.930 | 0.015 | 1.114 | 1.021 | 1.215 |
| XRCC4 | 0.084 | 0.035 | 5.728 | 0.017 | 1.088 | 1.015 | 1.166 |
| 53BP1 | − 0.020 | 0.034 | 0.352 | 0.553 | 0.980 | 0.918 | 1.047 |
| ERCC1 | 0.066 | 0.034 | 3.805 | 0.051 | 1.068 | 1.000 | 1.141 |
| XPA | 0.040 | 0.030 | 1.775 | 0.183 | 1.041 | 0.981 | 1.103 |